olmesartan

insulin ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23999037 Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation. 2014 Jan 23 1
2 22954201 Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients. 2013 3
3 23216584 Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies. 2013 Feb 1
4 23328189 Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure. 2013 Feb 1
5 23815562 Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies. 2013 Sep 1
6 21107432 Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study. 2011 Jun 1
7 21221601 Effects of olmesartan on blood pressure and insulin resistance in hypertensive patients with sleep-disordered breathing. 2011 Nov 1
8 21061834 Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women. 2010 Sep 2
9 18310964 Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. 2008 2
10 18622238 Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. 2008 Aug 1
11 18813860 Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study. 2008 Oct 4
12 17130263 Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade. 2006 Dec 1
13 15127887 Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. 2004 Apr 5